RxDoctor Payments Data

Jehad Saleh

Gerontology · Tampa, FLNPI 1891272076

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,440 of the $8,888 with a category attached, or 61.2%. 20 manufacturers reported payments, led by Medtronic at 50.8% of the total. 2025 is the largest year on record at $4,795, 6.5 times the $743 reported in 2021. Among gerontology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,888in general payments, 2019–2025

Across 115 payments — averaging $77.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$5K
  • Boston Scientific$2K
  • Amgen$626
  • AstraZeneca$341
  • Novo Nordisk$321
  • Pfizer$203
  • plus $1K from 14 others

What the payments were for

  • Travel & lodging$3,43139%
  • Food & beverage$5,44061%
  • Education$170%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,888 in reported general payments places this provider in the 95th percentile of 714 gerontology providers in Florida.

See all gerontology providers in Florida

Medicare billing

Part B allowed, 2024
$12,655
Medicare patients
73
Services billed
148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban60$49,320
Repatha SureclickEvolocumab36$33,888
BrilintaTicagrelor25$18,724
Ezetimibe18$817
Atorvastatin Calcium52$657
ClopidogrelClopidogrel Bisulfate53$615
Rosuvastatin Calcium52$613
Metoprolol Succinate41$537
Losartan Potassium50$472
Nifedipine ErNifedipine12$342
Amlodipine Besylate54$305
Carvedilol22$129
Furosemide30$76
Lisinopril22$64

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$203$49,32060 claims
AstraZenecaBrilinta$341$18,72425 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 714 gerontology providers in Florida.

Other gerontology in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →